SEER AYA Site Recode
The adapted classification scheme for tumors of adolescents and young adults (AYA) is based on the classification scheme proposed by RD Barr and colleagues1. The SEER AYA site recode variable was updated from the original ICD-O-2 based classification scheme using ICD-O-3 definitions for cancer morphology and topography.
The SEER AYA site recode was developed to better define the major cancer sites that affect individuals between 15 and 39 years of age. It is intended to facilitate the reporting of cancer incidence rates and trends. The SEER Cancer Statistics Review presents data by SEER AYA site recode groupings in Section 32, and the variable was added to the SEER databases as a convenience for researchers. The table
below contains definitions for the SEER AYA site recode variable.
The information provided in this table is also available in an ASCII text file (semicolons are used as the delimiters).
Site Group | ICD-O-3 Behavior Recode | Primary Site | ICD-O-3 Histology | Recode |
---|---|---|---|---|
1 Leukemias | ||||
1.1 Acute lymphoid leukemia | 3 | C000-C809 | 9826-9827, 9835-9837 | 01 |
1.2 Acute myeloid leukemia | 3 | C000-C809 | 9840, 9861, 9866-9867, 9871-9874, 9891, 9895-9897, 9910, 9920 | 02 |
1.3 Chronic myeloid leukemia | 3 | C000-C809 | 9863, 9875-9876 | 03 |
1.4 Other and unspecified leukemia | 3 | C000-C809 | 9742, 9800-9801, 9805, 9820, 9823, 9831-9834, 9860, 9870, 9930-9931, 9940, 9945-9946, 9948, 9963-9964 | 04 |
2 Lymphomas | ||||
2.1 Non-Hodgkin lymphoma | 3 | C000-C809 | 9590-9591, 9596, 9670-9671, 9673, 9675, 9678-9680, 9684, 9687, 9689-9691, 9695, 9698-9702, 9705, 9708-9709, 9714, 9716-9719, 9727-9729 | 05 |
2.2 Hodgkin lymphoma | 3 | C000-C809 | 9650-9655, 9659, 9661-9665, 9667 | 06 |
3 CNS and Other Intracranial and Intraspinal Neoplasms (all behaviors) | ||||
3.1. Astrocytoma | ||||
3.1.1 Specified low-grade astrocytic tumors | 0, 1, 3 | C723 | 9380 | 07 |
0, 1, 3 | C000-C809 | 9410-9411, 9420-9421, 9424 | 07 | |
3.1.2 Glioblastoma and anaplastic astrocytoma | 0, 1, 3 | C000-C809 | 9401, 9440-9442 | 08 |
3.1.3 Astrocytoma, NOS | 0, 1, 3 | C000-C809 | 9400 | 09 |
3.2 Other glioma | 0, 1, 3 | C000-C722,C724-C809 | 9380 | 10 |
0, 1, 3 | C000-C809 | 9381-9384, 9423, 9430, 9450-9451, 9460 | 10 | |
3.3 Ependymoma | 0, 1, 3 | C000-C809 | 9391-9394 | 11 |
3.4. Medulloblastoma and other PNET | ||||
3.4.1 Medulloblastoma | 0, 1, 3 | C716 | 9470-9474 | 12 |
3.4.2 Supratentorial PNET | 0, 1, 3 | C000-C715,C717-C809 | 9470-9474 | 13 |
3.5 Other specified intracranial and intraspinal neoplasms | 0, 1, 3 | C000-C699,C730-C750,C754-C809 | 9350-9351, 9360-9362, 9390, 9480, 9530-9535, 9537-9539, 9541, 9550, 9562, 9570 | 14 |
0, 1, 3 | C700-C729,C751-C753 | 9161, 9361-9362, 9390, 9530-9531, 9535, 9538, 9540, 9560, 9571 | 14 | |
0, 1, 3 | C700 | 9532, 9534, 9537, 9539 | 14 | |
0, 1, 3 | C753 | 9360 | 14 | |
0, 1, 3 | C711 | 9480, 9539 | 14 | |
0, 1, 3 | C713 | 9480, 9533 | 14 | |
0, 1, 3 | C719 | 9350 | 14 | |
0, 1, 3 | C714,C717 | 9480 | 14 | |
0, 1, 3 | C709 | 9539 | 14 | |
3.6 Unspecified intracranial and intraspinal neoplasms | ||||
3.6.1 Unspecified malignant intracranial and intraspinal neoplasms | 3 | C700-C729,C751-C753 | 8000-8005 | 15 |
3.6.2 Unspec. ben/border intracran. and intraspin. Neo. | 0, 1 | C700-C729,C751-C753 | 8000-8005 | 16 |
4 Osseous & Chondromatous Neoplasms | ||||
4.1 Osteosarcoma | 3 | C000-C809 | 9180-9187, 9192-9194 | 17 |
4.2 Chondrosarcoma | 3 | C000-C809 | 9220-9221, 9230-9231, 9240, 9242-9243 | 18 |
4.3 Ewing tumor | 3 | C000-C809 | 9260, 9364-9365 | 19 |
4.4 Other specified and unspecified bone tumors | 3 | C000-C809 | 8812, 9250, 9261, 9370-9372 | 20 |
3 | C400-C419 | 8000-8005, 8800-8803, 8805-8806, 9200 | 20 | |
5 Soft Tissue Sarcomas | ||||
5.1 Fibromatous neoplasms | 3 | C000-C809 | 8810-8811, 8813-8815, 8820-8824, 8830, 8832-8833, 8835-8836, 9252 | 21 |
5.2 Rhabdomyosarcoma | 3 | C000-C809 | 8900-8904, 8910, 8912, 8920-8921, 8991 | 22 |
5.3 Other soft tissue sarcoma | ||||
5.3.1 Specified soft tissue sarcoma | ||||
5.3.1.1 Specified (excluding Kaposi sarcoma) | 3 | C000-C809 | 8804, 8825, 8840-8897, 8982-8983, 8990, 9040-9044, 9120-9139, 9141-9150, 9170, 9251, 9561, 9580-9581, 9970 | 23 |
3 | C000-C699,C730-C750,C754-C809 | 9540, 9560, 9571 | 23 | |
5.3.1.2 Kaposi sarcoma | 3 | C000-C809 | 9140 | 24 |
5.3.2 Unspecified soft tissue sarcoma | 3 | C000-C399,C420-C809 | 8800-8803, 8805-8806 | 25 |
6 Germ Cell and Trophoblastic Neoplasms | ||||
6.1 Germ cell and trophoblastic neoplasms of gonads | 3 | C569,C620-C629 | 9060-9065, 9070-9073, 9080-9085, 9090-9091, 9100-9102, 9105 | 26 |
6.2 Germ cell and trophoblastic neoplasms of nongonadal sites | ||||
6.2.1 Intracranial (all behaviors) | 0, 1, 3 | C700-C729,C751-C753 | 9060-9065, 9070-9073, 9080-9085, 9090-9091, 9100-9102, 9105 | 27 |
6.2.2 Other nongonadal | 3 | C000-C568,C570-C619,C630-C699,C730-C750,C754-C809 | 9060-9065, 9070-9073, 9080-9085, 9090-9091, 9100-9102, 9104-9105 | 28 |
7 Melanoma and Skin Carcinomas | ||||
7.1 Melanoma | 3 | C000-C809 | 8720-8723, 8726, 8728, 8730, 8740-8746, 8761, 8770-8774, 8780 | 29 |
7.2 Skin carcinomas | 3 | C440-C449 | 8010-8589 | 30 |
8 Carcinomas | ||||
8.1 Thyroid carcinoma | 3 | C739 | 8010-8589 | 31 |
8.2 Other carcinoma of head and neck | ||||
8.2.1 Nasopharyngeal carcinoma | 3 | C110-C119 | 8010-8589 | 32 |
8.2.2 Other sites in lip, oral cavity and pharynx | 3 | C000-C109,C120-C148 | 8010-8589 | 33 |
8.2.3 Nasal cav,mid ear,sinuses,larynx,oth ill-def head/neck | 3 | C300-C329,C760 | 8010-8589 | 34 |
8.3 Carcinoma of trachea,bronchus, and lung | 3 | C330-C349 | 8010-8589 | 35 |
8.4 Carcinoma of breast | 3 | C500-C509 | 8010-8589 | 36 |
8.5 Carcinoma of genitourinary tract | ||||
8.5.1 Carcinoma of kidney | 3 | C649 | 8010-8589 | 37 |
8.5.2 Carcinoma of bladder | 3 | C670-C679 | 8010-8589 | 38 |
8.5.3 Carcinoma of gonads | 3 | C569,C620-C629 | 8010-8589 | 39 |
3 | C000-C809 | 8590-8593 | 39 | |
8.5.4 Carcinoma of cervix and uterus | 3 | C530-C559 | 8010-8589 | 40 |
8.5.5 Carc of other and ill-def sites, geniourinary tract | 3 | C510-C529,C570-C579,C600-C619,C630-C639,C659,C669,C680-C689 | 8010-8589 | 41 |
8.6 Carcinoma of gastrointestinal tract | ||||
8.6.1 Carcinoma of colon and rectum | 3 | C180-C218 | 8010-8589 | 42 |
8.6.2 Carcinoma of stomach | 3 | C160-C169 | 8010-8589 | 43 |
8.6.3 Carcinoma of liver and intrahepatic bile ducts | 3 | C220-C221 | 8010-8589 | 44 |
8.6.4 Carcinoma of pancreas | 3 | C250-C259 | 8010-8589 | 45 |
8.6.5 Carc other and ill-def sites, gastrointestinal tract | 3 | C150-C159,C170-C179,C230-C249,C260-C269 | 8010-8589 | 46 |
8.7 Carcinoma of other and ill-def sites | ||||
8.7.1 Adrenocortical carcinoma | 3 | C740-C749 | 8010-8589 | 47 |
8.7.2 Carcinoma of other and ill-defined sites, NOS | 3 | C149,C219,C222-C229,C270-C299,C350-C439,C450-C499,C561-C568,C580-C599,C640-C648,C650-C658,C660-C668,C690-C738,C750-C759,C761-C809 | 8010-8589 | 48 |
3 | C809 | 9010 | 48 | |
9 Miscellaneous specified neoplasms, NOS | ||||
9.1 Other pediatric and embryonal tumors, NOS | ||||
9.1.1 Wilms tumor | 3 | C000-C809 | 8959-8960 | 49 |
9.1.2 Neuroblastoma | 3 | C000-C809 | 9490, 9500 | 50 |
9.1.3 Other pediatric and embryonal tumors, NOS | 3 | C000-C809 | 8963-8964, 8970-8973, 8981, 9363, 9501-9523 | 51 |
9.2 Other specified and embryonal tumors, NOS | ||||
9.2.1 Paraganglioma and glomus tumors | 3 | C000-C809 | 8680-8711 | 52 |
9.2.2 Other specified gonadal tumors | 3 | C000-C809 | 8600-8650, 9000 | 53 |
3 | C569 | 8670, 9013-9015, 9054 | 53 | |
9.2.3 Myeloma, mast cell, misc. lymphoreticular neo., NOS | 3 | C000-C809 | 9731-9741, 9743-9764, 9766, 9769, 9960 | 54 |
9.2.4 Other specified neoplasms, NOS | 3 | C000-C809 | 8930-8951, 8980, 9020, 9050-9053, 9110, 9160, 9270-9330, 9950, 9962, 9980, 9982 | 55 |
3 | C421 | 9961, 9975, 9989 | 55 | |
3 | C000-C699,C730-C750,C754-C809 | 9161 | 55 | |
10 Unspecified Malignant Neoplasms | 3 | C000-C399,C420-C699,C730-C750,C754-C809 | 8000-8005 | 56 |
Unclassified | 99 |
1 Barr RD, Holowaty EJ, Birch JM. Classification Scheme for tumors diagnosed in adolescents and young adults. Cancer 2006;106(7):1425-30.